ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 38.85.
Share Price | ₹5,115.3 | May 07,2024 |
Market Cap | ₹61,178.4 Cr | |
Earnings-TTM | ₹1,574.7 Cr | TTM-Consolidated Results |
Price/Earnings | 38.85x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹61,178.4 Cr] as on May 07,2024
(/) Earnings [ ₹1,574.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 38.85x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 38.85 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 28.14x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.28x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ALKEM LABORATORIES | 1,574.66 | 38.85 | 61,178.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.40 | 363,535.0 |
CIPLA LTD | 3,744.03 | 29.93 | 112,058.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 18.77 | 104,414.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 33.40 | 98,676.3 |
DIVIS LABORATORIES LTD | 1,382.97 | 75.09 | 103,845.0 |
MANKIND PHARMA LTD | 1,743.30 | 50.96 | 88,830.5 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 59.29 | 88,586.4 |
LUPIN LTD | 1,935.57 | 37.92 | 73,400.8 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.72 | 65,903.5 |
ABBOTT INDIA LTD | 1,145.58 | 47.70 | 54,645.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.77x |
Max industry PE | 75.09x |
Median industry PE | 38.85x |
Average industry PE | 41.46x |
You may also like the below Video Courses